Alerts will be sent to your verified email
Verify EmailEIKO
|
Eiko Lifesciences
|
Kemistar Corporation
|
Alkali Metals
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
1.81 % | 3.76 % | 2.62 % |
|
5yr average Equity Multiplier
|
2.12 | 1.5 | 1.92 |
|
5yr Average Asset Turnover Ratio
|
0.56 | 0.64 | 0.83 |
|
5yr Avg Net Profit Margin
|
-3.7 % | 3.98 % | -0.2 % |
|
Price to Book
|
1.22 | 3.77 | 1.62 |
|
P/E
|
16.98 | 165.93 | 76.39 |
|
5yr Avg Cash Conversion Cycle
|
61.48 Days | 39.22 Days | 20.4 Days |
|
Inventory Days
|
214.38 Days | 41.97 Days | 130.73 Days |
|
Days Receivable
|
57.98 Days | 42.12 Days | 71.62 Days |
|
Days Payable
|
248.22 Days | 112.53 Days | 206.07 Days |
|
5yr Average Interest Coverage Ratio
|
-0.09 | 5.78 | 1.13 |
|
5yr Avg ROCE
|
-109.51 % | 5.14 % | 6.08 % |
|
5yr Avg Operating Profit Margin
|
-9.68 % | 7.79 % | 8.71 % |
|
5 yr average Debt to Equity
|
0.3 | 0.26 | 0.38 |
|
5yr CAGR Net Profit
|
60.2 % | 6.4 % | 44.52 % |
|
5yr Average Return on Assets
|
-4.56 % | 2.53 % | -0.12 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
39.91 % | 74.88 % | 69.59 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 30.06 % |
|
Change in Promoter Holding (3 Yrs)
|
16.18 % | -0.1 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Eiko Lifesciences
|
Kemistar Corporation
|
Alkali Metals
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|